Studies examining the effects of the IL6 polymorphism in patients with rheumatoid arthritis, which has been linked to elevated Lp(a) levels, have shown that blocking the IL6 receptor, but not TNF-α signaling, decreased Lp(a) levels by 30–40% [43,44]. The gene discussed is TNF; the disease is rheumatoid arthritis.